ADCY5 and diabetes mellitus: Given that hyperglycemia is a major metabolic abnormality in diabetes, we propose that this AKAP5/P2Y11/AC5/PKA/CaV1.2 nanocomplex could be involved in the development of diabetic vascular complications.